Navigation Links
Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study

new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. As a result of these and other risks and uncertainties, actual results may differ materially from those described in this press release. For further information with respect to factors that could cause actual results to differ from expectations, reference is made to reports filed by the Company with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. The forward-looking statements made in this release are made only as of the date hereof and Insmed disclaims any intention or responsibility for updating predictions or financial guidance contained in this release.

Contact

Investor Relations International
Haris Tajyar, 818-382-9702
htajyar@irintl.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference
2. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
3. Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study
4. State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:10/6/2008)...nking polyphenol-rich 100% Concord grape,juice was...ntake or body,weight, CONCORD, Mass., Oct. 6 /PRN...-rich Concord grape juice did not cause significan...appetite and was shown to reduce waist,circumferen...ual Meeting of,the American College of Nutrition i...
(Date:10/3/2008)...ase Inhibitors for Cancer Treatments, INDIANAPOLI...stCall/ --,Eli Lilly and Company (NYSE: LLY ) and...ay announced that the two companies have entered,i...ent related to,Deciphera,s preclinical B-Raf kinas...ology therapeutics., The collaboration will apply...
(Date:10/2/2008)...RNewswire/ -- Calabar AB announced today,that thei... mouth"),patients has been initiated. Specifically...s between the ages of 20 to 75. The objective of t...ucceeding Phase III efficacy,study., Xalieve(TM) ...hysostigmine. It is administered locally in the mo...
(Date:10/1/2008)...tial of Amylin,s integrated neurohormonal ... DIEGO, Oct. 1 /- Amylin Ph...ed that new data for its pipeline obesity,candidat... Meeting of The,Obesity Society in Phoenix October...of the largest and most comprehensive scientific c...
Breaking Medicine Technology:Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7Docs Issue Guideline on Screening for Osteoporosis in Men 18604 1Docs Issue Guideline on Screening for Osteoporosis in Men 18604 2iCAD Reports First Quarter 2008 Financial Results 5164 1iCAD Reports First Quarter 2008 Financial Results 5164 2iCAD Reports First Quarter 2008 Financial Results 5164 3iCAD Reports First Quarter 2008 Financial Results 5164 4iCAD Reports First Quarter 2008 Financial Results 5164 5iCAD Reports First Quarter 2008 Financial Results 5164 6iCAD Reports First Quarter 2008 Financial Results 5164 7iCAD Reports First Quarter 2008 Financial Results 5164 8iCAD Reports First Quarter 2008 Financial Results 5164 9Pharm Olam Finds VoIP Solution in Taridium LLC 5160 1Pharm Olam Finds VoIP Solution in Taridium LLC 5160 2Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 1Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 2Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 3Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 4Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 5Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 6Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 7Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 8Advanced Life Sciences Announces First Quarter 2008 Financial Results 5158 9
...ING, N.J.--(BUSINESS WIRE)--Apr 19, 2007 - Antares...ts from a recently completed,site application stud...TD(TM) transdermal gel, was absorbed on a bioequiv...ee different skin site,locations., The study was a...lication site pharmacokinetic study. The trial enr...
...Unique Viral Kinetics Profile, LAUSANNE, Switzerla...p (Debiopharm), a global independent biopharmaceut...s medical conditions,presented additional results...ilin (Cyp) inhibitor Debio 025 in HIV/HCV (hepatit...esented at the 42nd,Annual Meeting of the European...
Other Medicine Technology:Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4
(Date:10/6/2008)... Lutherville-based civil litigation and criminal...on Co. after jury awarded $3.2 million to plaintif...herville, Maryland ((Lexis Nexis) October 6, 2008 ...l.com/ [Miller, Murtha & Psoras] have successf...lf of a Maryland welder who was awarded more than ...
(Date:10/5/2008)...considerable disparities in survival related to ra...ead and neck cancer. Published in the November 15,...f the American Cancer Society, the study indicates...tment could improve outcomes for these cancers amo... studies have examined disparities in cancer survi...
(Date:10/5/2008)...ospitalized kids with painful ailments from broken...killing drugs known as opiates. The medications bl...nstipation, for instance, is one side effect that ...spital stay. , "No parent wants their child in t...Sharek, MD, MPH, medical director for quality mana...
(Date:10/5/2008)...tle exercise goes a long way toward helping severe... and complete important daily tasks, according to ..., In a pre-program assessment where patients repo...per week, individuals who were more active reporte...ed improvements in their ability to perform daily ...
Breaking Medicine News(10 mins):Health News:Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel 2Health News:News from Cancer: Disparities in head and neck cancer patients 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 3Health News:A little exercise goes a long way for severely obese 2
...s from the Harvard School of Public Health now rev...n health risks. They have found that women who car...isk of coronary heart disease. The findings were r... which had collected data on caregiving and corona...
...ming in laboratory studies that one of the substan...hives--may inhibit the development of tooth decay...., found that propolis// considerably reduces denta...r of glucosyltransferase (Gtf) enzymes, enzymes th...
...fferent specialties, recently joined hands to demo...er patients. Dr. Peter Costantino, an otolaryngolo...n fatal tumor in Angela Carrozza’s nasal cavity an...iety of Clinical Oncology, nearly 38,000 cases of ...
...illion people go to the Emergency Room(ER) with ch... Most receive an ECG and other standard tests to d...r serious heart problems. However, ECGs can be com... place. ECGs are also sometimes unable to identify...
Other Medicine News:
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: